Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03915431 · ClinicalTrials.gov registry record · Phase 1

A Study of NCS-01 in Patients With Acute Ischemic Stroke

A Phase 1 study of Ischemic Stroke, sponsored by NC Medial Research.

Active
Registry status
Phase 1
Development phase
16
Enrollment target
1
Study location

NCT03915431 is a Phase 1 study of Ischemic Stroke that is active but no longer recruiting, run by NC Medial Research. The registered enrollment target is 16 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03915431, a Phase 1 study of Ischemic Stroke, is active but no longer recruiting, sponsored by NC Medial Research.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

This is an initial Phase1/2 dose-finding, randomized, multi-center study to evaluate the safety and tolerability of NCS-01 in patients with acute ischemic stroke. All patients will be randomized within 48 hours of stroke onset. This study will be conducted in 2 stages.

Conditions Studied

Ischemic Stroke

Interventions

  • BIOLOGICAL NCS-01

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2020-02-27
Est. Completion 2028-10
Phase Phase 1

Sponsor

NC Medial Research

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03915431

The ClinicalTrials.gov registry entry for NCT03915431 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (99% lower). The listed sponsor is NC Medial Research, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which NCS-01 is the first listed.

NCT03915431 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03915431 about?

NCT03915431 is a clinical study titled "A Study of NCS-01 in Patients With Acute Ischemic Stroke". This is an initial Phase1/2 dose-finding, randomized, multi-center study to evaluate the safety and tolerability of NCS-01 in patients with acute ischemic stroke. All patients will be randomized within 48 hours of stroke onset. This study will be conducted in 2 stages.

What is the current status of trial NCT03915431?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2020-02-27. Estimated completion is 2028-10.

What conditions does trial NCT03915431 study?

This clinical trial studies the following conditions: Ischemic Stroke.

What interventions are being tested in trial NCT03915431?

The interventions under investigation include: NCS-01 (BIOLOGICAL).

Who is sponsoring clinical trial NCT03915431?

This trial is sponsored by NC Medial Research, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03915431 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ischemic Stroke

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.